Innovation

Los Angeles-based Cedars-Sinai joined a $31 million funding round for Vita Therapeutics, a company that uses genetics to develop new cellular therapies to treat muscular dystrophy and cancer.

Minneapolis-based Allina Health has launched hospital-at-home company Inbound Health with a $20 million investment.

Biotechnology company Surge Therapeutics raised $26 million in series A financing.

Healthcare venture capitalist firm General Catalyst has led a $168 million series B funding round for biotech company Odyssey Therapeutics.

University Park, Pa.-based Penn State University has received a $599,883 grant from the National Science Foundation to develop machine learning algorithms that can better analyze messy healthcare data.

Large health systems are fueling healthcare innovation by making their own investments in biotech and therapeutics startups as their size, relationships with academic researchers, dedicated venture arms and internal spinout gives them a better opportunity to invest, according to a…

The vast majority of FDA-approved medical devices enabled by artificial intelligence or machine learning are concentrated in radiology and cardiovascular care, according to an analysis by Rock Health.

"Hospital-at-home" programs have been rapidly expanding across the country, as health systems aim to treat patients in the often more comfortable and less expensive home environment.

Microsoft has partnered with GSK's consumer health spinoff Haleon to make it easier for people who are blind, have low-vision or difficulty with reading to access information on packaging labels.

Researchers at the University of Buffalo (N.Y.) are working on Conscientiousness Coach, an app used to treat cognitive decline in multiple sclerosis patients.